Series A · Healthtech · Geneva, Switzerland · Founded 2020 · 6–10 employees
Adiposs is a clinical-stage Swiss biotech developing ImageBAT, the first medical imaging product to make brown adipose tissue visible on standard CT scans. This revolutionary contrast agent enables early detection of cachexia in cancer patients and predicts response to cancer immunotherapy. The company recently completed a CHF 4 million Series A funding round to advance clinical development. ImageBAT has completed Phase I clinical trials and is moving to Phase II trials in oncology patients.
No open roles listed right now.